Live feed08:03:00·114dPRReleasevia QuantisnowJohnson & Johnson therapy nipocalimab granted U.S. FDA Fast Track designation in systemic lupus erythematosus (SLE)ByQuantisnow·Wall Street's wire, on your screen.JNJ· Johnson & JohnsonHealth Care
